Journal of International Oncology››2012,Vol. 39››Issue (3): 206-208.

Previous ArticlesNext Articles

BRAFV600Egene mutation and papillary thyroid cancer

JIAO Xiao-Ping, WANG Sheng-Ying

  1. The First Department of Surgery Oncology,First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China
  • Online:2012-03-08Published:2012-02-24
  • Contact:WANG Sheng-ying, E-mail: wangshengying61@yahoo.com.cn

Abstract:The BRAFV600Emutation in papillary thyroid carcinoma is the most common genetic event, which is an invasive tumor clinical phenotype and a poor prognosis indicator. The BRAFV600Emutation detection has an important guiding significance for the differential diagnosis of malignant thyroid nodules on preoperative, guiding the surgical resection range of thyroid cancer, judging the patient’s prognosis and guiding the subsequent treatment of postoperative

Key words:color: black,font-family: "Times New Roman",mso-ansi-language: EN-US,mso-fareast-language: ZH-CN,mso-bidi-language: AR-SA,mso-fareast-font-family: 宋体,mso-font-kerning: 1.0pt">Thyroid neoplasms,Adenocarcinoma, papillary,Point mutation